![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, December 02, 2015 8:51:11 PM
Re: None
Post # of 46290
What level of investment required to establish biologics production on two continents? For BMY it's nearly 2 billion dollars and their second facility won't be operational until 2019
Bristol-Myers Squibb to Build Biologics Plant in Ireland
Pharmaceutical Company Expects to Invest About $900 Million in New Facility
By
Michael Calia
Nov. 14, 2014 6:30 a.m. ET
0 COMMENTS
Bristol-Myers Squibb Co. on Friday said it plans to build a biologics plant in Cruiserath, Ireland, as the pharmaceutical company expands its global manufacturing presence.
Bristol-Myers said it expects the cost of the new plant to be comparable to the roughly $900 million it paid to build a biologics facility in Devens, Mass. The company said it expects to finalize the cost of the new plant during the second half of 2015.
Bristol-Myers said it expects about 350 to 400 scientists, engineers and other staffers to work at the Ireland site once construction is completed. The company projects the facility will be operational in 2019.
The move comes as biologic medicines are being used increasingly to treat major diseases, the company said, adding that the drugs make up more than half of its research-and-development pipeline.
Ireland has become a hot spot for the pharmaceutical industry, as U.S. companies have sought to expand in the country through so-called inversion deals that lower tax bills.
Write to Michael Calia at michael.calia@wsj.com
I'm here primarily for the pop up ads I'm just that impulsive......
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM